H2: Groundbreaking approach uses cyclic peptide nanotubes to deliver doxorubicin to cancer cell nuclei A team at CiQUS (University of Santiago de Compostela, Spain) has unveiled a novel molecular strategy that enables anticancer drugs to reach the nucleus of tumor cells, enhancing their therapeutic impact. Focusing on doxorubicin, a cornerstone chemotherapy drug, the researchers show…